Neuraxis, INC

NRXS NYSE CIK: 0001933567

Company Information

Industry Electromedical & Electrotherapeutic Apparatus
SIC Code 3845
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 11611 N. MERIDIAN ST, CARMEL, IN, 46032
Mailing Address 11611 N. MERIDIAN ST, CARMEL, IN, 46032
Phone (812) 689-0791
Fiscal Year End 1231
EIN 455079684

Financial Overview

FY2024

-$8.24M
Net Income
$4.76M
Total Assets
$2.69M
Total Liabilities
$2.07M
Stockholders' Equity
$3.70M
Cash & Equivalents
$-1.22
EPS

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report February 13, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 3, 2026 View on SEC
4 Insider stock transaction report January 30, 2026 View on SEC
4 Insider stock transaction report January 30, 2026 View on SEC
4 Insider stock transaction report December 29, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment November 12, 2025 View on SEC
10-Q Quarterly financial report November 10, 2025 View on SEC
8-K Current report of material events October 24, 2025 View on SEC
8-K Current report of material events October 23, 2025 View on SEC
424B5 Prospectus supplement October 23, 2025 View on SEC

Insider Trading

STRONG BUY 2 insiders 3 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3845)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.